AKSU, S. Et Al. 2015. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML. 20th Congress of European-Hematology-Association , (Vienna, Austria), 690.

AKSU, S., Aktimur, S. H., Arica, D. C., Atay, H., Bektas, O., BÜYÜKAŞIK, Y., ... DEMİROĞLU, H.(2015). GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML . 20th Congress of European-Hematology-Association (pp.690). Vienna, Austria

AKSU, SALİH Et Al. "GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML," 20th Congress of European-Hematology-Association, Vienna, Austria, 2015

AKSU, SALİH Et Al. "GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML." 20th Congress of European-Hematology-Association , Vienna, Austria, pp.690, 2015

AKSU, S. Et Al. (2015) . "GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML." 20th Congress of European-Hematology-Association , Vienna, Austria, p.690.

@conferencepaper{conferencepaper, author={SALİH AKSU Et Al. }, title={GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML}, congress name={20th Congress of European-Hematology-Association}, city={Vienna}, country={Austria}, year={2015}, pages={690} }